However, when compared to patients without baseline anemia, those patients from the Hb-R subgroup had a similar functional improvement, whereas patients from the Hb-NR subgroup had a significantly lower likelihood of functional improvement with ≧2 NYHA classes. This evidence concerns the gene GSTM1 and anemia.